PATENT CLAIM ANALYSIS

Application Number: 16158085
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-06
Patent Classification: ["514", "560000"]

Abstract:
The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and methods of using same to treat a variety of conditions and disorders.

Claim (Index 9):
The method of  claim 7 , wherein about 0.5 g, about 1 g or about 2 g of DGLA or derivative thereof is orally administered to the subject per day.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 97.0
- Lexical Diversity: 1.09091
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15661374', '14730818', '15667683', '14307195', '14059529']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7225696542919771
- 35 USC 102 Novelty (BERT): 0.5466400451039415
- Combined Prediction Score: 0.7049766933731735
- Mean Citation Score: 255.813158
- Max Citation Score: 377.79144
- Similarity Product: 228.80207016386032

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test